Clinical Trials for Juvenile Rheumatoid Arthritis
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Juvenile Rheumatoid Arthritis is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Juvenile Rheumatoid Arthritis:
- The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006)
- Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab/anti-TNF alfa
- Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - gamma-Linolenic acid
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,cyclosporine,filgrastim,methylprednisolone,prednisone
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-Thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders - This study is currently recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,filgrastim
- Study of High-Dose Cyclophosphamide and Anti-Thymocyte Globulin With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-thymocyte globulin,cyclophosphamide,filgrastim
- BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
- PEAK Study (Physical Exercise and Activity in Kids) - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS - This study is currently recruiting patients (Current: 23 Nov 2006) - Anakinra
- The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - TNFR:Fc
- ENBREL(R) (Etanercept) Safety Study in Children With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - ENBREL(R) (etanercept)
- Safety and Efficacy Study of Etanercept (Enbrel) In Children With Systemic Onset Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel®
- Meloxicam [Mobic] Suspension in Juvenile Rheumatoid Arthritis (JRA) - This study has been completed (Current: 23 Nov 2006) - meloxicam oral suspension,naproxen oral suspension
- A One Year Double-Blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in JRA/JIA - This study has been completed (Current: 23 Nov 2006) - meloxicam 0.25 mg/kg,meloxicam 0.125 mg/kg,naproxen 10 mg/kg
- Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Calcium carbonate
- TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Enbrel
- Meloxicam Suspension in Juvenile Rheumatoid Arthritis (JRA) - This study has been completed (Current: 23 Nov 2006) - Meloxicam
- Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Anakinra
- Registry of Etanercept (Enbrel) In Children With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel®
- Juvenile Rheumatoid Arthritis Research Registry - This study is currently recruiting patients (Current: 23 Nov 2006)
- Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
- Long-Term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
- Long-Term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
- Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - MRA(Tocilizumab)
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
- A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis - This study has been completed (Current: 23 Nov 2006) - Infliximab
- Human Anti-Tac (Daclizumab) to Treat JIA-Associated Uveitis - This study is currently recruiting patients (Current: 23 Nov 2006) - HAT,Daclizumab
- Effects of Growth Hormone in Chronically Ill Children - This study is no longer recruiting patients (Current: 23 Nov 2006) - Growth Hormone
- Study of Arthritis and Related Conditions - This study is currently recruiting patients (Current: 23 Nov 2006)
- Infliximab to Treat Children With Juvenile Rheumatoid Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Infliximab
- Alendronate Osteoporosis Study - This study is no longer recruiting patients (Current: 23 Nov 2006) - Alendronate
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Juvenile Rheumatoid Arthritis:
The trial data on this page has been sourced from
